Brighton Jones LLC’s Pfizer PFE Stock Holding History

Brighton Jones LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-435,487	Closed	-$10.8M	–	40
2025 Q4	$10.8M	Sell	435,487 -122,536	-22%	-$3.09M	0.4%	31
2025 Q3	$14.2M	Buy	558,023 +15,246	+3%	+$376K	0.34%	44
2025 Q2	$13.2M	Sell	542,777 -118,942	-18%	-$2.77M	0.36%	42
2025 Q1	$16.8M	Sell	661,719 -4,599	-0.7%	-$120K	0.54%	34
2024 Q4	$17.7M	Buy	666,318 +618,117	+1,282%	+$16.8M	0.51%	35
2024 Q3	$1.39M	Sell	48,201 -1,053,385	-96%	-$30.7M	0.05%	179
2024 Q2	$30.8M	Buy	1,101,586 +979,310	+801%	+$27M	1.02%	14
2024 Q1	$3.39M	Buy	122,276 +60,956	+99%	+$1.69M	0.12%	94
2023 Q4	$1.77M	Buy	61,320 +205	+0.3%	+$6.2K	0.07%	146
2023 Q3	$2.03M	Sell	61,115 -3,789	-6%	-$134K	0.1%	111
2023 Q2	$2.38M	Buy	64,904 +5,764	+10%	+$224K	0.12%	100
2023 Q1	$2.41M	Buy	59,140 +10,199	+21%	+$441K	0.14%	95
2022 Q4	$2.51M	Buy	48,941 +219	+0.4%	+$10.5K	0.15%	84
2022 Q3	$2.13M	Buy	48,722 +874	+2%	+$42.5K	0.13%	89
2022 Q2	$2.51M	Buy	47,848 +48	+0.1%	+$2.45K	0.15%	81
2022 Q1	$2.47M	Buy	47,800 +3,280	+7%	+$170K	0.12%	91
2021 Q4	$2.63M	Buy	44,520 +5,459	+14%	+$270K	0.12%	89
2021 Q3	$1.68M	Buy	39,061 +1,137	+3%	+$50.4K	0.09%	106
2021 Q2	$1.49M	Sell	37,924 -10,035	-21%	-$390K	0.08%	115
2021 Q1	$1.74M	Buy	47,959 +828	+2%	+$29.4K	0.1%	93
2020 Q4	$1.74M	Sell	47,131 -1,079	-2%	-$39.6K	0.11%	87
2020 Q3	$1.68M	Buy	48,210 +6,320	+15%	+$222K	0.12%	76
2020 Q2	$1.3M	Sell	41,890 -632	-1%	-$21.5K	0.11%	83
2020 Q1	$1.32M	Buy	42,522 +2,676	+7%	+$91.2K	0.14%	74
2019 Q4	$1.48M	Buy	39,846 +1,042	+3%	+$37.1K	0.16%	83
2019 Q3	$1.32M	Sell	38,804 -2,767	-7%	-$101K	0.15%	86
2019 Q2	$1.71M	Sell	41,571 -722	-2%	-$28.7K	0.2%	68
2019 Q1	$1.7M	Sell	42,293 -6,616	-14%	-$265K	0.21%	65
2018 Q4	$2.02M	Buy	48,909 +3,013	+7%	+$125K	0.29%	44
2018 Q3	$1.92M	Buy	45,896 +4,348	+10%	+$167K	0.24%	50
2018 Q2	$1.43M	Buy	41,548 +9,351	+29%	+$320K	0.18%	70
2018 Q1	$1.08M	Sell	32,197 -3,998	-11%	-$137K	0.15%	84
2017 Q4	$1.24M	Sell	36,195 -4,961	-12%	-$169K	0.15%	82
2017 Q3	$1.39M	Sell	41,156 -3,204	-7%	-$103K	0.18%	70
2017 Q2	$1.41M	Buy	+44,360	New	+$1.4M	0.2%	61
2017 Q1	–	Sell	-11,853	Closed	-$365K	–	116
2016 Q4	$365K	Sell	11,853 -28,909	-71%	-$883K	0.14%	62
2016 Q3	$1.31M	Sell	40,762 -1,426	-3%	-$47.7K	0.21%	55
2016 Q2	$1.41M	Sell	42,188 -1,424	-3%	-$45.4K	0.25%	52
2016 Q1	$1.23M	Sell	43,612 -1,214	-3%	-$34.7K	0.23%	54
2015 Q4	$1.37M	Sell	44,826 -1,114	-2%	-$35K	0.27%	45
2015 Q3	$1.37M	Sell	45,940 -2,896	-6%	-$92.9K	0.29%	43
2015 Q2	$1.55M	Buy	48,836 +3,090	+7%	+$101K	0.36%	37
2015 Q1	$1.51M	Sell	45,746 -3,284	-7%	-$104K	0.34%	36
2014 Q4	$1.45M	Sell	49,030 -27,574	-36%	-$791K	0.33%	42
2014 Q3	$2.15M	Buy	76,604 +20,032	+35%	+$562K	0.48%	25
2014 Q2	$1.59M	Sell	56,572 -3,980	-7%	-$113K	0.36%	34
2014 Q1	$1.84M	Buy	60,552 +3,481	+6%	+$104K	0.43%	29
2013 Q4	$1.64M	Buy	57,071 +13,004	+30%	+$378K	0.37%	33
2013 Q3	$1.2M	Buy	44,067 +11,437	+35%	+$311K	0.31%	39
2013 Q2	$867K	Buy	+32,630	New	+$902K	0.26%	38

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Brighton Jones LLC's PFE Position: Q1 2026 in Review

Brighton Jones LLC sold out of Pfizer (PFE) in Q1 2026, closing a stake of 435,487 shares — an estimated $10.8M sold.

Brighton Jones LLC first reported a position in PFE in Q2 2013 and held it in 50 quarters. The position peaked at $30.8M in Q2 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Brighton Jones LLC reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Brighton Jones LLC sold 435,487 Pfizer shares in Q1 2026, an estimated $10.8M.
Brighton Jones LLC first reported a position in Pfizer in Q2 2013 and held it in 50 quarters.
Brighton Jones LLC's Pfizer position peaked at $30.8M in Q2 2024.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.